Turmeric and curcumin as adjuncts in controlling Helicobacter pylori -associated diseases: a narrative review
Letters in Applied Microbiology · 03.06.2024 · 77 (6)
DOI: 10.1093/lambio/ovae049 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Letters in Applied Microbiology, online erschienen am 24.05.2024. Verfasst von Lyudmila Boyanova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Medical University of Sofia, 1431 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Curcumin, Helicobacter Infections, Helicobacter pylori, Curcuma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Medical University of Sofia.
Abstract (Originalsprache)
Non-antibiotic adjuncts may improve Helicobacter pylori infection control. Our aim was to emphasize curcumin benefits in controlling H. pylori infection. We discussed publications in English mostly published since 2020 using keyword search. Curcumin is the main bioactive substance in turmeric. Curcumin inhibited H. pylori growth, urease activity, three cag genes, and biofilms through dose- and strain-dependent activities. Curcumin also displayed numerous anticancer activities such as apoptosis induction, anti-inflammatory and anti-angiogenic effects, caspase-3 upregulation, Bax protein enhancement, p53 gene activation, and chemosensitization. Supplementing triple regimens, the agent increased H. pylori eradication success in three Iranian studies. Bioavailability was improved by liposomal preparations, lipid conjugates, electrospray-encapsulation, and nano-complexation with proteins. The agent was safe at doses of 0.5–>4 g daily, the most common (in 16% of the users) adverse effect being gastrointestinal upset. Notably, curcumin favorably influences the intestinal microbiota and inhibits Clostridioides difficile. Previous reports showed the inhibitory effect of curcumin on H pylori growth. Curcumin may become an additive in the therapy of H. pylori infection, an adjunct for gastric cancer control, and an agent beneficial to the intestinal microbiota. Further examination is necessary to determine its optimal dosage, synergy with antibiotics, supplementation to various eradication regimens, and prophylactic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Medical University of Sofia, 1431 Sofia, Bulgaria.
- Gastroenterology Clinic, Rua do Carmo, 75-1º AA,, 3000 Coimbra, Portugal.
ORCID-Profile: Lyudmila Boyanova
Förderung
- Medical University of Sofia
Zitieren
APA
Boyanova, L., Medeiros, J., Yordanov, D., Gergova, R., & Markovska, R. (2024). Turmeric and curcumin as adjuncts in controlling Helicobacter pylori -associated diseases: a narrative review. Letters in Applied Microbiology, 77(6). https://doi.org/10.1093/lambio/ovae049
Vancouver
Boyanova L, Medeiros J, Yordanov D, Gergova R, Markovska R. Turmeric and curcumin as adjuncts in controlling Helicobacter pylori -associated diseases: a narrative review. Letters in Applied Microbiology. 2024;77(6). doi:10.1093/lambio/ovae049
BibTeX
@article{Boyanova2024,
author = {Boyanova, Lyudmila and Medeiros, José and Yordanov, Daniel and Gergova, Raina and Markovska, Rumyana},
title = {Turmeric and curcumin as adjuncts in controlling Helicobacter pylori -associated diseases: a narrative review},
journal = {Letters in Applied Microbiology},
year = {2024},
volume = {77},
number = {6},
doi = {10.1093/lambio/ovae049}
}
EUVIMED